Study of the Penumbra Coil 400 System to Treat Aneurysm (ACE)

Penumbra

Status

Completed

Conditions

Intracranial Aneurysms

Peripheral Aneurysms

Treatments

Device: PC 400 coils (Penumbra )

Study type

Interventional

Funder types

Industry

Identifiers

NCT01465841

CLP 4492 (Other Identifier)

Details and patient eligibility

About

This is a prospective, multi-center study of patients with intracranial or peripheral aneurysms who are treated by the PC 400 System. The primary objective is to gather post market data on the Penumbra Coil 400 (PC 400) System in the acute treatment of intracranial and peripheral aneurysms. Approximately 2,000 patients with intracranial or peripheral aneurysms treated by the PC 400 System at up to 100 centers will be enrolled. Data for each patient are collected up to discharge or 3 days post-procedure, whichever occurs sooner. Long term follow-up to one year will be conducted in accordance to the standard of care at each participating hospital.

Enrollment

517 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients enrolled in this study must be those treated according to the cleared indication for the PC 400 System which is for the endovascular embolization of:

Intracranial aneurysms
Other neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulae
Arterial and venous embolizations in the peripheral vasculature

Exclusion criteria

Patients in whom endovascular embolization therapies other than Penumbra Coils are used will be excluded from this study. However, adjunctive use of balloon and stent are acceptable.